Out-licensing: Diagnostic/Biomarker-based Diagnostics

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 1..10 of 54 - per page Next page
Order by

Cripto-1 Represents a Biomarker for Chronic Inflammatory Diseases

Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More

Diagnostic Method to Detect Endometriosis

A non-invasive development of a test for the diagnosis and monitoring of endometriosis. More

A Battery of Genetic Biomarkers of Severe Outcome in Patients with Elevated Triglyceride Levels

A renowned cardiologist and Robarts' Scientist has identified a strong correlation between a polymorphism of a relatively new apolipoprotein gene and severity of hypertiglyceridemia manifestation. More

Novel Therapeutic Target for Pancreatic Cancer (PD2)

Novel target and monoclonal antibody for early diagnosis and/or therapeutic intervention More

Novel target anti-lung cancer siRNA therapies, treatment drugs

Neomics has found a very promising target, AIMP2/AIMP2-DX2 for siRNA therapy application to tumoric lung cancer cells and we intend to focus the remaining resources on developing through clinical trials, the siRNA therapy as a first priority More

Therapeutic Target and Antibody for Prostate Cancer

Therapeutic method to treat prostate carcinomas by administration of cellular PAcP protein. More

Assay for identification of diabetic patients likely to develop kidney disease

A simple blood based assay to identify diabetic patients who are likely to develop or have early stage diabetic nephropathy has been developed at King's. This has the potential to be used regularly at diabetic clinics. More

Pancreatic Cancer Specific Target (MUC17)

Recently characterized MUC17 gene highly specific for pancreatic cancer. More

A Rapid, Point-of-Care Device for Diagnosis of Acetaminophen Toxicity (08-27)

Acetaminophen-protein Adduct Dipstick: rapid, sensitive and specific diagnostic device for point-of-care determination of acetaminophen toxicity More

Pancreatic Cancer Target (MUC4)

Diagnostic and potential therapeutic applications for mucin gene 4 (MUC4). More

Displaying 1..10 of 54 - per page Next page
Order by

Your selection

Industry sector: Diagnostic del; Biomarker-based diagnostics del

Browse By

Therapeutic target: Accident and Trauma; Allergy; Blood and forming organs; Cardiovascular; Central Nervous System; Dermatological; Endocrinology; Gastrointestinal; Genetic disorders; Genito-urinary; Hospital and Surgery; Immune related disorders; Infectious diseases; Metabolism; Musculoskeletal; Oncology; Oral Health; Other therapeutic; Respiratory; Sensory organ
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us